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Animal studies have found that prior stressful events can result in increased reactivity in the HPA-axis. However, baseline function of the
HPA-axis has typically been normal or decreased in post-traumatic stress disorder (PTSD). The first purpose of this study was to assess
cortisol responsivity to traumatic reminders in women with PTSD related to childhood abuse. The second aim was to assess the
relationship between stress-induced cortisol levels and neutral and emotional memory. Salivary cortisol levels were measured before,
during and after exposure to personalized trauma scripts in abused women with (N¼ 12) and without current PTSD (N¼ 12). Memory
for neutral and emotional material was assessed immediately after trauma scripts exposure and 3 days later. PTSD patients had 122%
higher cortisol levels during script exposure, 69% higher cortisol levels during recovery, and 60% higher levels in the period leading up to
the script exposure compared to controls. PTSD symptoms were highly predictive of cortisol levels during trauma script exposure
(r¼ 0.70), but not during periods of rest. Both in PTSD patients and controls, memory consolidation after the trauma scripts was
impaired relative to baseline (Po0.001), with no differences between the two groups on memory performance. There was no
association between memory performance and cortisol levels. These results are consistent with higher cortisol levels following exposure
to traumatic stressors in PTSD.
Neuropsychopharmacology (2003) 28, 1656–1665, advance online publication, 02 July 2003; doi:10.1038/sj.npp.1300226






















































Childhood sexual or physical abuse is associated with
increased rates of a variety of psychiatric disorders,
including post-traumatic stress disorder (PTSD), depres-
sion, alcohol and substance abuse, dissociative disorders,
and borderline personality disorder (McCauley et al, 1997;
Beitchman et al, 1992; Brown and Anderson, 1991; Draijer
and Langeland, 1999). A recent survey in the US reported
that childhood sexual abuse is the most common cause of
PTSD in women, currently affecting 10% of all women
(Kessler et al, 1995). There is a growing body of evidence in
animals demonstrating that early adverse events, such as
maternal deprivation, may have a lasting impact on the
neurobiology of the stress response, involving chronic
increases in plasma glucocorticoid levels and a potentiation
of glucocorticoid responsiveness to subsequent stressors
(Sapolsky, 1997; Plotsky and Meany, 1993; Anisman et al,
1998). In humans, trauma early in life appears to increase
the risk of developing PTSD in adulthood in response to
other traumas, suggesting that early trauma reduces the
capacity to cope with subsequent stressful events (Bremner
et al, 1993). In spite of the high prevalence of childhood
abuse and PTSD, little is known about the long-term effects
of abuse on the regulation of stress.
Two biological stress systems, that is, the locus coeruleus/
noradrenergic system and the hypothalamic–pituitary–
adrenal (HPA) axis are likely to mediate the association
between early life stress and PTSD. Long-term alterations in
these stress systems, both at baseline (‘tonic’) and with
exposure to trauma cues (‘phasic’), have been documented
in PTSD subjects (Bremner et al, 1999). Exposure of
patients with PTSD to scripts of the individual’s traumatic
experiences have resulted in an increase in sympathetic
responses (eg heart rate, systolic and diastolic blood
pressure, skin conductance, and (nor)epinephrine) in
comparison to traumatized persons without PTSD (Pitman
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et al, 1990, 1987; Liberzon et al, 1999; Orr et al, 1993; Shalev
et al, 1993).
Unlike the increased sensitivity of the locus coeruleus/
noradrenergic system, baseline and challenge studies show
that the HPA-axis functions in a more complicated manner.
Shortly after a traumatic event (ie the ‘phasic’ responses),
cortisol secretion is generally enhanced, as was found in
soldiers being shelled (Howard et al, 1955), and in women
shortly after being raped (Resnick et al, 1995; Yehuda et al,
1998). Paradoxically, basal 24-h cortisol excretion has been
reported to be lower in patients with PTSD compared to
controls (Mason et al, 1986; Yehuda et al, 1990, 1995b,
1996). This may be due to enhanced adrenocortical
sensitivity to feedback regulation, given reports of enhanced
dexamethasone suppressibility in PTSD (Yehuda et al, 1993;
Stein et al, 1997) or decreased responsiveness of the adrenal
cortex (Kanter et al, 2001). Other studies have reported
increased cortisol in 24-h urine volumes both in combat
veterans with PTSD (Pitman and Orr, 1990), in women with
PTSD secondary to childhood sexual abuse (Lemieux and
Coe, 1995), and in maltreated children with PTSD (De Bellis
et al, 1999). In line with these latter studies, elevated levels
of CRF in the cerebrospinal fluid (CSF) have been found in
combat-related PTSD (Bremner et al, 1997). In sum, studies
examining baseline HPA-axis function in patients with
PTSD have been inconsistent, with evidence both for hypo-
and hypersecretion of cortisol.
As PTSD patients specifically suffer from exaggerated
stress responses to trauma cues, it is particularly relevant to
evaluate the reactivity of the HPA-axis to traumatic
reminders. So far, studies have largely focused on baseline
differences between PTSD patients and controls. One study
of adult women with depression and early abuse found
increased cortisol and ACTH responses to a stressful
cognitive challenge (Heim et al, 2000). Recently, in a study
on neuroendocrine responses to white noise and combat
sounds, veterans with PTSD showed enhanced cortisol
levels compared to veteran controls without PTSD and
nonveteran controls (Liberzon et al, 1999). However, the
timeframe of the cortisol assessment (only once before and
once immediately after exposure) was inappropriate to
distinguish baseline levels and cortisol reactivity to stress.
Thus, it remained unclear whether elevations reflected
enhanced chronic activation or anticipatory anxiety to the
combat sounds and white noise. To our knowledge, no
other studies have been published that directly assessed
responsivity of the HPA-axis in relation to traumatic
stimuli.
Recent findings shave shown that the HPA-axis plays an
important role in memory functioning by its effects on the
hippocampus (Bremner, 1999; Elzinga and Bremner, 2002;
McEwen, 2000; McGaugh, 2000; Sapolsky, 1996), a brain
structure involved in learning and memory (Squire and
Zola-Morgan, 1991). Studies in animals show that high
levels of GCs may have a long-term inhibitory effect on
memory function with GC-mediated hippocampal toxicity
and memory dysfunction with stress (McEwen et al, 1992;
Sapolsky, 1996; Arbel et al, 1994; Conrad et al, 1996; Luine
et al, 1994; Ohl et al, 2000). Studies in humans have also
found declarative memory impairments in healthy subjects
after administration of exogenous glucocorticoids (Keenan
et al, 1995; Wolkowitz et al, 1990; Newcomer et al, 1994,
1999; Lupien et al, 1997, 1999) and with exposure to real-life
stressors (Kirschbaum et al, 1996). In our lab, we found that
a psychosocial laboratory stressor specifically impaired
consolidation of information (Elzinga et al, submitted).
There are indications that PTSD patients are character-
ized by increased sensitivity of central GC receptors in the
hippocampus (Yehuda et al, 1995a). If so, exposure to stress
in patients with PTSD might result in greater impairments
of declarative memory compared to control subjects. This
might explain why patients with PTSD report a variety of
memory disturbances, including deficits in new learning,
fragmentation of (trauma-related) autobiographical mem-
ories, and trauma-related amnesia (for a review, see Elzinga
and Bremner, 2002; Golier and Yehuda, 1998). So far, no
study has directly assessed the relationship between stress-
induced cortisol elevations and neutral and emotional
memory functioning in PTSD.
The purpose of the present study was to assess cortisol
levels following exposure to personalized trauma scripts in
women with current PTSD related to childhood abuse and
women with a history of abuse without current PTSD. We
hypothesized higher cortisol levels following exposure to
trauma scripts in PTSD patients relative to controls. To
investigate the relationship between cortisol levels during
encoding and memory performance, neutral and emotional
words and paragraphs were presented immediately after
exposure to the trauma scripts to assess stress-related
memory functioning and 3 days later to assess delayed recall
of the information and baseline memory functioning.
SUBJECTS AND METHODS
Subjects
A total of 24 women with a history of severe sexual and/or
physical abuse participated in this study. Subjects included
women with (N¼ 12) and without (N¼ 12) current PTSD
related to childhood abuse (for subject characteristics, see
Table 1). All subjects had lifetime PTSD. Subjects were
recruited by advertisements in newspapers and flyers, and
were paid for participation in the study. They were free of
clinically significant medical or neurological illnesses.
Subjects were excluded if they presented with a history of
current alcohol or substance abuse or dependence in the
past 6 months, organic mental disorders, or comorbid
psychotic disorders based on the Structured Clinical Inter-
view for DSM-IV axis I disorders (SCID-I; First et al, 1995).
Of the 12 control subjects, five were taking psychotropic
medication during participation in the study (two subjects
were using 20 mg paroxetine, one was using 40 mg
nefazadone, one was using 250 mg sertraline, and one was
using 300 mg bupropion), and four of 12 PTSD subjects
(two were using 10 mg paroxetine, one was using 20 mg
paroxetine, and one was using 40 mg citalopram). Subjects
using benzodiazepines were excluded from the study
because of the known negative effects on memory
functioning. After an introduction to the study, all subjects
gave written informed consent for their participation in a
protocol approved by the Human Investigation Committee
of Yale University. The procedure was in accord with the
Helsinki Declaration of 1975.
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History of childhood abuse was assessed with the Early
Trauma InventoryFself-report version (ETI; Bremner et al,
2000), a reliable and valid inventory that assesses physical,
emotional, and sexual abuse, as well as general traumatic
events (Bremner et al, 2000). Subjects were included with a
history of childhood physical or sexual abuse, defined as
rape, attempted rape, molestation, physical assault or attack
with injury, before the age of 18 years. Axis I diagnoses were
assessed with the SCID-I disorders (First et al, 1995, see
Table 1). Current and lifetime PTSD was assessed with the
Clinician-Administered PTSD Scale for DSM-IV (CAPS-DX;
Blake et al, 1997), a reliable and valid measure of PTSD
symptoms with subcomponents for the individual symptom
clusters. PTSD subjects had to fulfill the DSM-IV criteria for
PTSD and have a total CAPS score of 50 or higher. Subjects
with CAPS scores lower than 50 and who did not fulfill the
DSM-IV criteria were included as control subjects. Baseline
dissociative traits were assessed by the Dissociative
Experience Scale (DES; Bernstein and Putnam, 1986).
Depressive mood was assessed using the Hamilton Rating
Scale for Depression (HRSD; Hamilton, 1960).
Scripts
Prior to the challenge day, the subject prepared two
personalized scripts with the assistance of an interviewer,
using a prior published method (Pitman et al, 1987;
Bremner et al, 1999). The participant was first asked to
describe a severe childhood sexual or physical abuse event
on a script preparation form (trauma script 1). The
participant’s response was reviewed and a script approxi-
mately 1 min in length was composed by the interviewer
portraying the experience in the first person, present tense.
Then the participant was asked to describe a second
traumatic situation, that is, a situation in which the person
felt left alone or abandoned (trauma script 2). Again, a
script was composed of about 1 min in length describing the
event in the first person, present tense. As cortisol
responses only arise after approximately 20 min starting
from the onset of the stressful situation, the contribution of
each individual script on cortisol response cannot be
specified. Specific effects of the two scripts on the heart
rate, blood pressure, and skin conductance are reported
elsewhere (Schmahl et al, submitted).
The subjective impact of the personal trauma scripts was
assessed after each script on a 17-item PTSD symptom scale
(Southwick et al, 1993); a Clinician-Administered Dissocia-
tive States Scale (CADSS, Bremner et al, 1998), a reliable
and valid 27-item scale for the measurement of current
dissociative states; a Subjective Units of Distress Scale (a
visual analog scale ranging from 0 to 100) for the
assessment of current subjective levels of distress; and a
Visual Analog Scale (ranging from 0 to 100) for the
assessment of anxiety.
Memory Tasks
Paragraph recall. The Wechsler Memory Scale-Revised
Logical Memory test (Wechsler, 1987) was used as a valid
and sensitive measure of verbal declarative memory that has
Table 1 Subject Characteristics
PTSD (n¼ 12) Controls (n¼12)
Mean7SD Mean7SD P-value two-tailed
Mean age (years) 35.677 9.94 38.757 10.47 NS
Height 65.087 2.50 64.507 2.15 NS





Education (years) 14.367 2.69 16.087 2.71 NS
Comorbid diagnoses
MDD 3 0
Other anxiety disorders 4 (2 Soc Ph, GAD, PD) 2 (PDwA, Social Ph)
Early trauma inventory 76.507 23.45 74.897 44.25 NS
General trauma 25.007 11.62 28.107 17.23 NS
Physical abuse 11.927 8.81 14.007 10.79 NS
Emotional abuse 23.587 11.20 14.447 14.14 NS
Sexual abuse 16.007 10.53 15.707 10.31 NS
CAPS total 79.007 11.78 19.087 12.24 0.0001
CAPS-B (re-experiencing) 15.837 5.22 3.927 4.08 0.0001
CAPS-C (avoidance) 32. 837 7.90 6.837 6.83 0.0001
CAPS-D (arousal) 30.337 6.60 8.337 5.65 0.0001
DES 15.667 17.03 8.457 7.86 NS
Hamilton rating scale-D 10.457 4.57 1.787 1.39 0.0001
Note: Soc Ph¼ social phobia; GAD¼ generalized anxiety disorder; PD¼ panic disorder; PdwA¼ panic disorder
with agoraphobia.
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proved to be sensitive to GC effects in previous studies
(Newcomer et al, 1994, 1999). The Wechsler memory task is
a typical example of declarative memory, using encoding
and retrieval strategies. Participants heard two short
narratives. Recall for the 25 embedded facts was tested
immediately and following a 30 min intervening period,
during which other neuropsychological tests were per-
formed. Two versions (A and B) of the Wechsler memory
tests were administered, one after exposure to the trauma
scripts, and one 3 days later, which served as a baseline
measure. To avoid any nonrandom errors, order of
presentation of the two paragraphs was counterbalanced.
It was expected that due to enhanced cortisol levels,
immediate and delayed recall of the narrative adminis-
tered immediately after the stress challenge would be
impaired compared to the immediate and delayed
recall of the narrative presented under resting conditions
at day 3.
To assess memory processing of relevant, emotional
material, an emotional paragraph was developed (of a
woman alone in her house who got assaulted by her
neighbor), also containing 25 embedded facts. To study the
effects of stress-induced increases in cortisol levels on
encoding and retrieval, this narrative was learned and
recalled after exposure to the personalized scripts. To assess
the effects of cortisol on long-term consolidation, recall of
the story was again assessed 3 days later.
Word recall. Participants received a list of 20 emotional,
trauma-related words (eg ‘tortured’, ‘blood’). In a pilot
study, these words were rated as more fearful, sad, nervous,
angry, and less happy than neutral words (all Po0.0001).
All words had unique word-stems. The investigator (BE)
read the words out loud and subjects were instructed to rate
how fearful each word was on a 5-point scale. The words
were then read a second time, instructing subjects to rate
how aversive the word was. To study the effects of cortisol
on encoding, word recall was tested 3 days later in a
surprise-cued recall task, a word-stem completion task, and
a recognition task. It was expected that elevated cortisol
levels would be associated with impaired performance on
the explicit memory tasks.
For the cued recall task, 10 word-stems were presented
corresponding to 10 trauma words instructing the subjects
to fill in the word-stems with words that were previously
presented. For the word-stem completion task, the 10
remaining target word-stems (not presented in the cued
recall task) were presented intermixed with 10 filler word-
stems that did not correspond to any previously presented
words, to obscure the goal of memory testing. Subjects were
instructed to fill in the first word that came to mind. In the
recognition task, all 20 target words were presented
intermixed with 20 new trauma words. Subjects had to rate
how confident they were that they had seen the word before
at day 1 using the following rating scale: 1. I’m sure that the
word is new (not studied); 2. Probably new; 3. Probably old;
4. Sure that the word is old (or studied). Subjects were given
2 points each time they assigned a ‘4’ (sure that the word is
old) to a target word, 1 point for each ‘3’, 1 point for each
‘2’, and 2 points for each ‘1’. The total score served as a
measure of emotional recognition memory.
Gordon box distractibility task. To control for attention,
distractibility was measured using a computer-generated
continuous performance task that presented a rapid,
continual sequence of numbers in one of three positions,
right, center, or left (Gordon Diagnostic System (GDS);
Gordon and Mettelman, 1987). In a first presentation,
participants had to press a key every time they saw a ‘9’. In a
second presentation, participants were required to respond
by pressing a key to each ‘9’ that appeared immediately after
a ‘1’, but only if they both appeared sequentially in the
center position. The total number of correct responses and
reaction latencies were analyzed.
Cortisol
Cortisol levels were monitored using saliva sampling to
prevent the stress-inducing effects of blood sampling.
Determination of cortisol in saliva provides a reliable
measure of the free unbound fraction of cortisol (Tunn et al,
1992). Saliva samples were collected at 14 time-points
before, during, and after the trauma scripts exposure. Pre-
exposure levels of cortisol were assessed at 20, 10, 5, and
0 min before exposure to the scripts; cortisol levels during
trauma exposure were assessed at 5, 10, 15, and 20 min after
exposure to the first trauma script, and cortisol levels
during recovery were assessed at 25, 30, 40, 50, 60, and
75 min after exposure to the first trauma script (see
Figure 1). Saliva samples were collected using Salivette
collection devices and stored at 701C. Salivette tubes were
centrifuged (0–41C) to prepare saliva, which was analyzed
for cortisol using a 125I immunoradiometric assay kit
available from Diagnostic Products Corporation (Los
Angeles, CA). Samples and standards (200 ml) were deter-
mined in duplicate. Day-to-day coefficients for low (389 pg/
ml) and high (4.12 ng/ml) concentration quality assessment
(QC) samples were 10.1 and 8.4%, respectively.
Procedure
The study was conducted in the afternoon (between 1400
and 1700 hoursp.m.) in order to have a standard time-point
relative to normal diurnal cortisol variations. Participants



















Figure 1 Cortisol levels (mg/dl) and standard error of means (SEMs)
before, during, and after trauma script exposure for women with and
without PTSD. Women with PTSD had elevated levels of cortisol during
and shortly after the script exposure compared to controls (t0–t25).
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had to refrain from strenuous physical exercise, large meals,
cigarette smoking, and coffee for at least 1 h prior to the
experiment, because of the known effects of these variables
on cortisol secretion. Subjects were placed in a quiet room
in a reclining chair. After a resting period of 20 min, a
standardized neutral story 1 min in length was read by a
female investigator. Subjects were then asked to imagine the
story for 2 min. After the imagination period, subjective
ratings of PTSD symptoms, dissociation, anxiety, and
general distress were collected. After 30 min, the first
personal trauma script was read out loud, followed by an
imagination period of 2 min in which subjects were asked to
imagine the script as vividly as possible. After this, the
subjective ratings were assessed. This procedure was
repeated after 10 min with the presentation of the second
trauma script. The order of the two scripts was randomized.
After exposure to the trauma scripts, subjects had a resting
period of 5 min after which the memory assessment took
place in the same fixed order: Wechsler paragraph (A)
immediate recall; rating of emotional words; learning and
immediate recall of the emotional story; Wechsler para-
graph (A) delayed recall; and two distractibility tasks. The
complete procedure took about 1.5 h.
At 3 days after the script exposure, subjects came back for
a 30-min memory assessment. In a same fixed order, the
following memory tests were administered: Wechsler
paragraph (B) immediate recall (baseline); word-stem
completion, cued recall and recognition task of the
emotional words; delayed paragraph recall of emotional
story; and Wechsler paragraph (B) delayed recall (baseline).
STATISTICS
Cortisol levels during the experiment were calculated using
repeated measures design with the 14 separate time-points
as the within-subject factor and the PTSD vs control group
as the between-subject factor. Differences in cortisol levels
at separate time-points between the two groups were
calculated using t-tests for independent samples (two-
tailed). Memory performance between the two groups was
calculated using t-tests for paired samples (two-tailed).
Paragraph recall before and after stress exposure was
analyzed using a 2 (immediate vs delayed recall) by 2
(stress vs baseline) repeated measures design followed by
post hoc t-tests. Subjective measures were calculated using a
repeated measures design with the two diagnostic groups as
the between-subject factor and the three scripts (neutral,
trauma script 1, and trauma script 2) as the within-subject
factor, followed by post hoc t-tests. Correlations between
cortisol levels and CAPS scores, and between cortisol levels
and memory performance were calculated using Pearson’s
correlations.
RESULTS
Cortisol Levels in Response to Trauma Scripts
Abused women with PTSD demonstrated higher cortisol
levels compared to controls (main effect for diagnosis:
F[1,22]¼ 4.08, P¼ 0.056, Figure 1). Cortisol levels were
elevated by an average of 122% in PTSD patients compared
to controls during script exposure (mean of time-points 5,
10, 15, and 20 min; t(22)¼ 2.82, Po0.01), vs 60% during the
pre-exposure period (mean of time-points 20, 10, 5,
and 0 min; t(22)¼ 1.51, NS), and 69% during the post-
exposure period (mean of time-points 25, 30, 40, 50, 60, and
75 min: t(22)¼ 1.66, NS). Comparisons at separate time-
points revealed that women with PTSD had significantly
higher cortisol levels than controls during and shortly after
the script exposure (time-points t0–t25): tt0(22)¼ 2.17,
Po0.05; tt5(22)¼ 2.19, Po0.05; tt10(22)¼ 2.28, Po0.05;
tt15(22)¼ 2.83, Po0.01; tt20(22)¼ 3.19, Po0.01; and
tt25(22)¼ 2.23, Po0.05, all two-tailed (see asterixes in
Figure 1).
For the group as a whole, cortisol levels were lower during
the postexposure period (from 25 min onwards) than before
and during script exposure (ie significant main effect for
time: F[13,299]¼ 6.00, Po0.001). This main effect of time
was specified by a significant group by time interaction
(F[13,286]¼ 1.95, Po0.05): Abused women with PTSD
exhibited a strong decrease in cortisol after the script
exposure, whereas controls did not.
To examine the effect of depression on cortisol levels,
PTSD patients with (n¼ 3) and without (n¼ 9) a comorbid
depression were compared. No differences were detected
(mean cortisol of women without depres-
sion¼ 0.0827 0.052 mg/dl vs mean cortisol of women with
depression¼ 0.0757 0.014mg/dl). To assess the effects of
medication on cortisol levels, mean cortisol levels of
medicated subjects with (n¼ 4) and without PTSD (n¼ 5)
were compared to cortisol levels of unmedicated subjects
with (n¼ 8) and without PTSD (n¼ 7). In both groups,
mean cortisol levels were somewhat lower in medicated
subjects (PTSD¼ 0.0717 0.008mg/dl and controls¼ 0.0167
0.004 mg/dl) relative to unmediated subjects (PTSD¼
0.0867 0.056mg/dl and controls¼ 0.0657 0.043mg/dl).
This effect appeared to be stronger in the control group,
but sample sizes were too small to allow statistical
analyses.
Correlations Between Cortisol and PTSD
Symptomatology
Correlations between cortisol levels and severity of PTSD
symptoms as assessed with the Clinician-Administered
PTSD Scale (CAPS) during the diagnostic assessment
(indicating the severity of post-traumatic symptoms during
the past 2 weeks) were high during and shortly after
exposure to the trauma scripts, but moderate under resting
conditions (both pre- and postexposure) (see Figure 2,
correlations higher than7 0.40 are significant at the 0.05
level). Re-experiencing symptoms (subscale B) and arousal
symptoms (subscale D) were especially correlated with
cortisol release, whereas avoidance behavior (subscale C)
yielded lower correlations.
Subjective Measures
Abused women with PTSD reported more PTSD symptoms,
dissociative symptoms, and anxiety to the trauma scripts
than abused women without PTSD (Table 2). For the sample
as a whole, exposure to the trauma scripts resulted in
elevated PTSD symptoms (F[2,44]¼ 36.41, Po0.001), dis-
sociative symptoms (F[2,44]¼ 7.64, Po0.001), anxiety
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(F[2,44]¼ 11.76, Po0.001), and subjective distress
(F[2,44]¼ 24.38, Po0.001) compared to the neutral script.
No interaction was found between the script and group.
Memory
Compared to the abused women without current PTSD,
abused women with PTSD tended to recall less emotional
words 3 days after the challenge day, and recognized new
words less well than words not previously studied (see
Table 3). With Bonferroni correction, these differences were
no longer significant. No differences were found between
the two groups on (neutral or emotional) paragraph recall at
the day of the challenge or at baseline.
In a repeated-measures ANOVA on the immediate vs
delayed recall of the (neutral) paragraphs after exposure vs
baseline, the average recall after the trauma script exposure
was impaired relative to the average recall during baseline
(F[1,21]¼ 49.41, Po0.001). The expected main effect of
time was also found (F[1,21]¼ 6.81, Po0.05), indicating
that delayed paragraph recall was decreased compared to
immediate recall. Interestingly, these main effects were
specified by a significant interaction between time and
testing condition (F[1,21]¼ 8.41, Po0.01). A post hoc
analysis revealed that delayed recall was particularly
decreased after the script exposure (delayed paragraph
recall after stress exposure¼ 12.467 3.84 units vs delayed
paragraph recall during baseline¼ 16.577 4.30 units,
t(22)¼3.39, Po0.01), whereas immediate recall was not
(immediate recall after stress exposure¼ 15.207 4.05 units
vs immediate recall during baseline¼ 17.187 4.20 units,
t(22)¼1.53, NS).
Correlations with Cortisol
A positive correlation was found between cortisol levels
during encoding (t30) and recall of the emotional paragraph
at day 3 (r¼ 0.48, Po0.05). No other significant correla-
tions were found between cortisol levels and recall of the
neutral or emotional paragraphs at day 3 or with any other
measure of memory function immediately after the stress
exposure.
DISCUSSION
Women with PTSD demonstrated significantly elevated
cortisol levels compared to abused women without PTSD
when exposed to personalized scripts of childhood abuse,
with the greatest magnitude of elevations during and shortly
after exposure to the trauma scripts. During recovery,
cortisol levels in the PTSD group dropped significantly to a
level similar to the non-PTSD group. Taken together, these
findings are consistent with findings of increased negative
feedback sensitivity (Yehuda et al, 1993; Stein et al, 1997).
In conjunction with prior studies showing decreased or
normal cortisol levels at baseline, these findings may
suggest increased cortisol levels following exposure to
stress with suppressed baseline activation.
During and shortly after exposure to the trauma scripts,
cortisol levels were strongly associated with PTSD symp-
toms as assessed with the CAPS. Thus, the severity of PTSD
symptoms experienced during the 2 weeks prior to the
study was highly predictive of cortisol levels with exposure
to the trauma scripts. This was particularly true for re-
experiencing and arousal symptoms, and less so for
avoidance (that measures behavior rather than an ‘internal
state’). It was striking that both before and after exposure to








































Figure 2 Mean Pearson’s correlations between cortisol levels at the
separate time-points during the study and baseline PTSD symptomatology
as measured with the CAPS during diagnostic assessment. Note:
Correlations higher than7 0.40 are significant at the 0.05 level.
Table 2 Mean (7 SD) Psychological Ratings for Women with and without PTSD After Listening to a Neutral Script, and the Two Trauma
Scripts Describing Their Childhood Abuse
Neutral Script Trauma Script 1 Trauma Script 2
PTSD (n¼ 12) Mean7SD Mean7SD Mean7SD F P-value two-tailed
PTSD symptoms 21.677 11.92 37.257 15.06* 32.837 15.30* 28.49 0.000t14t24n
CADSS 6.257 9.37* 13.007 18.42* 9.757 13.90* 5.88 0.090t14t24n
Anxiety 1.177 1.03 2.177 1.03* 1.757 1.22* 20.32 0.000t14t24n
SUDS 22.257 22.94 46.677 25.44 40.837 26.36 27.33 0.000t1+t24n
Controls (n¼ 12)
PTSD symptoms 16.177 4.39 27.587 10.22* 24.427 5.79* 11.35 0.000t1+t24n
CADSS 0.677 0.98* 2.927 4.94* 1.337 1.83* 1.86 0.180t1¼ t2¼ n
Anxiety 0.587 0.67 0.837 0.94* 0.757 0.87* 0.76 0.480t1¼ t2¼ n
SUDS 20.837 17.30 36.257 25.60 35.177 22.10 5.86 0.009t1+t24n
Note: CADSS: Clinician-Administered Dissociative States Scale; SUDS: Subjective Units of Distress Scale; *Significant main effect for diagnosis (Po0.05, one-sided).
t1¼ trauma script 1; t2¼ trauma script 2; n¼ neutral script.
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the trauma scripts, correlations between cortisol and CAPS
scales dropped to nonsignificant levels, indicating that
PTSD symptoms are not a good predictor of cortisol levels
under resting conditions.
This pattern of results may provide new insights into the
mixed findings on baseline HPA-axis functioning in PTSD,
with several studies reporting lowered (Mason et al, 1986;
Yehuda et al, 1990, 1996), and others reporting elevated
levels of cortisol measured in 24-h urine in patients with
PTSD (Pitman and Orr, 1990; Lemieux and Coe, 1995; De
Bellis et al, 1999). Rather than a consistent pattern of static
‘hypocortisolism’ or ‘hypercortisolism’, (internal or exter-
nal) confrontations with traumatic reminders or other
stressful conditions may determine levels of cortisol, with
decreases in cortisol levels being related to suppression of
cortisol function to compensate for periods of increased
cortisol levels during stress. This is supported by the finding
of marked lability of urinary free cortisol levels at
admission, midcourse, and discharge during a 90-day
hospitalization period in male Vietnam combat veterans
with PTSD (Mason et al, 2002).
Women with PTSD, and control subjects to a lesser
extent, had higher cortisol levels before being exposed to
the trauma scripts than during the period following the
scripts exposure. This probably reflects heightened HPA
activity due to anticipatory anxiety, as the women were
informed about the procedure, and all were anxious in
anticipation of it. Previous studies have demonstrated that
anticipation of a stressful event may be a potent activator of
HPA activity, with HPA activation often starting even before
an acute stressor is applied (Kirschbaum et al, 1993; Richter
et al, 1996). Moreover, elevated levels of cortisol were also
found in PTSD patients in anticipation of a cognitive stress
challenge (Bremner et al, 2003b). Owing to this lack of a
proper baseline, it could not be determined with certainty
whether cortisol levels had increased in PTSD patients in
response to the trauma scripts (starting already prior to the
experiment). The significant drop in cortisol levels during
the recovery phase may suggest that this was the case.
Moreover, a large part of the present sample took part in a
study on the assessment of the HPA-axis over a 24-h diurnal
period and in response to neuroendocrine challenges, in
which lower levels of cortisol were found for the PTSD
women during the afternoon hours (12–8 pm) compared to
non-PTSD women (see Bremner et al, 2003a). Clearly,
future studies on stress responsivity of the HPA-axis in
PTSD should also assess proper baseline cortisol levels,
measured on a separate day than the challenge.
In both PTSD patients and controls, memory consolida-
tion was impaired following stress exposure compared to
baseline measurements. However, this appeared to be
independent of cortisol levels. With Bonferroni correction,
no differences were found between the two groups in the
recall of emotional or neutral words or paragraphs. More-
over, we did not find any of the expected negative
correlations between cortisol and memory performance.
One explanation for this may be related to the fact that
exposure to the trauma scripts caused rather moderate
elevations in cortisol levels. The peak levels of cortisol were
(far) below cortisol levels associated with memory impair-
ments in healthy subjects who have been exposed to a
psychosocial stress challenge (Kirschbaum et al, 1996;
Elzinga et al, submitted) or to synthetic cortisol (Lupien
et al, 1999; Kirschbaum et al, 1996). Apparently, stressors
with the duration and the intensity of the trauma scripts do
not induce cortisol levels high enough to reduce memory
Table 3 Memory Data of Women with and without PTSD
PTSD (n¼ 12) Controls (n¼ 12)
Memory tasks Mean7SD Mean7SD P-value two-tailed
Neutral paragraph recall A (stress cond.)
Immediate recall (day 1) 14.717 4.05 16.047 4.12 NS
Delayed recall (day 1) 12.587 4.66 12.927 3.46 NS
Percentage recall 84.47 20.27% 81.27 13.19% NS
Neutral paragraph recall B (baseline)
Immediate recall (day 3) 18.057 4.10 16.387 4.30 NS
Delayed recall (day 3) 17.237 4.51 15.967 4.21 NS
Percentage recall 95.07 8.75% 98.4%7 11.61 NS
Emotional paragraph recall
Immediate recall (day 1) 14.837 4.39 15.177 3.07 NS
Delayed recall (day 3) 6.807 4.75 7.007 4.53 NS
Percentage recall 49.97 29.02% 44.57 23.87% NS
Emotional word recall (day 3)
Cued recall 0.857 0.97 1.887 1.52 0.07
Implicit memory 00.467 0.64 0.547 0.66 NS
Recognition (old) 14.727 7.31 21.367 6.77 NS
Recognition (new) 1.007 6.62 8.187 7.28 0.03
Distractibility task (day 1)
No. of correct answers 29.087 1.83 28.917 1.81 NS
Reaction time 49.677 10.85 48.457 20.84 NS
Note: Percentage recall¼ (delayed recall/immediate recall) 100.
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functioning. It cannot be dismissed, however, that more
elevated cortisol levels, elicited by exposure to more intense
or aversive stressors (eg chronic stressors or highly
emotional or traumatic events such as sexual or physical
abuse) may be associated with decreases in memory
functioning.
The only significant correlation that did arise was a
positive relation between cortisol levels and recall of the
emotional story, so that the higher the cortisol, the better
the story was recalled. The positive correlation was
inconsistent with our hypothesis based on prior studies
(Newcomer et al, 1994, 1999; Kirschbaum et al, 1996).
However, these studies included only neutral material.
Based on animal studies, it might be hypothesized that
cortisol has a differential effect on neutral vs emotional
memory performance. Emotional arousal may enhance
memory functioning due to a complex interaction between
corticosteroids and adrenergic activity in the basolateral
nucleus of the amygdala (McGaugh, 2000; Roozendaal,
2000). This was supported by a recent study in healthy
subjects reporting enhancing effects of cortisol on the recall
of emotional pictures (Buchanan and Lovallo, 2001).
Clearly, more studies with various levels of both stress-
induced and pharmacologically administered cortisol need
to be conducted to gain more insight into the association
between various cortisol levels, norepinephrine, and mem-
ory functioning related to neutral and emotional events.
Several limitations should be considered in evaluating our
findings. First, the sample size was rather small with 12
women with and 12 women without current PTSD. Second,
about a third of the subjects, equally distributed among the
two groups, was taking psychotropic medication during the
investigation. As evidence is accumulating that antidepres-
sants may reduce reactivity of the HPA-axis, more studies
are needed that investigate the effects of cortisol reactivity
in nonmedicated vs medicated PTSD patients and control
subjects. Moreover, all subjects, including the control
subjects, had a lifetime diagnosis of PTSD. It is still
unknown whether the cortisol responses of traumatized
women with a history of PTSD can be generalized to
individuals with a history of childhood abuse who have
never developed PTSD. This would be another interesting
question for future study. Furthermore, no subjects were
included who had no history of sexual or physical abuse and
no PTSD. It cannot be dismissed that nonabused healthy
individuals may show even higher cortisol levels in response
to similar stressors compared to the two abused samples.
Instead of PTSD patients showing elevated cortisol levels
following exposure to traumatic reminders, this would
rather be indicative of a relative hyposecretion of cortisol in
abused individuals without current PTSD. For a definite
answer to this interesting issue, a direct comparison among
these three groups would be necessary. Obviously, in such a
study, participants would have to be exposed to a more
general type of stressor, as a nonabused group can by
definition not generate a personal trauma script as was used
in the present study. Another limitation is that only cortisol
levels were assessed in this study. To study HPA regulation
in more detail, the separate components of the stress axis
need to be measured, including ACTH. Moreover, the HPA-
axis and the locus coeruleus/noradrenergic system have
mutual interconnections. PTSD may be associated with
dysfunctional connectivity between those systems. It would
be informative, therefore, to assess these different stress
systems within one study.
A question that arises from this study is whether the
pattern of elevated cortisol levels in patients with PTSD
when confronted with traumatic reminders will be reduced
after successful treatment. As all women in the control
group had a lifetime diagnosis of PTSD, this might suggest
that this is indeed the case. To study this issue more
directly, cortisol responses to trauma scripts both before
and after either pharmacological or psychological treatment
should be assessed.
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